Increasingly, the care of lung cancer patients has become a multi-doctor, multi-disciplinary job. Gone are the days (thankfully!) when a paternalistic doctor prescribed a treatment plan that was unquestioned by the patient. The internet and ease of travel have allowed unprecedented access to information and to physicians. As more treatment options and strategies become available for lung cancer patients, it is inevitable that they will be faced with differing opinions from their physicians with regard to how to personalize their care. Examples are plentiful, such as decisions between surgery or radiation therapy… Read More
#LCSM Chat Topic 4/6: Who Needs Research Anyway: How Have You Been Impacted by Lung Cancer Research?
Our topic for the next #LCSM Chat on Thursday, April 6th at 5 PM Pacific/ 8 PM Eastern is “Who Needs Research Anyway: How Have You Been Impacted by Lung Cancer Research?” The moderator for this chat is Dr. David Tom Cooke (@DavidCookeMD) In its most recent budget outline, the Trump administration is looking to propose an 18% cut to the National Institute of Health’s (NIH; @NIH) $31.7 billion budget (#trumpbudget). In addition to this funding cut, the Trump administration proposes to 1) reorganize the current NIH institute structure and 2)… Read More
Please join the #lcsm community and moderator @BrendonStilesMD for our first #LCSM Chat of 2017 on Thursday, January 12th, at 8 pm Eastern Time (5 pm Pacific). The topic of the chat will be “Lung cancer: who is at risk?” Many in our own #lcsm community have either had lung cancer themselves or have family members who have been affected. It is common therefore to wonder “Is my family at risk?” or “Am I next?” While exposure to tobacco smoke is the most well-known risk factor for lung cancer, other significant risk factors exist…. Read More